Table 2. Persistence days of post-recovery of COVD-19 recorded symptoms in 979 studied subjects.
Descriptive Statistics | Mean (days) | Median (days) | Standard Deviation | Range (days) | No. | % | p-value | |
---|---|---|---|---|---|---|---|---|
I-General Symptoms | Fatigue Days | 7 | 5 | 8.6 | 120 | 719 | 73% | 0.004* |
Weakness Days | 8.1 | 5 | 9.8 | 119 | 715 | 73% | 0.001* | |
II- Skin and Musculoskeletal symptoms | Muscle aches Days | 7.8 | 5 | 12 | 119 | 646 | 66% | 0.14 |
Joint pains Days | 7.2 | 5 | 9.4 | 119 | 595 | 61% | 0.01* | |
Skin Rash Days | 5.4 | 2 | 11.7 | 119 | 164 | 17% | 0.62 | |
III- Psychological and Neurological symptoms | Headache Days | 6.5 | 4 | 8.2 | 119 | 627 | 64% | 0.73 |
Mood changes Days | 9.5 | 7 | 11.9 | 154 | 501 | 51% | 0.03* | |
Insomnia Days | 8.8 | 7 | 10.6 | 89 | 432 | 44% | 0.21 | |
Paraesthesia and anesthesia Days | 7 | 4 | 11.1 | 119 | 296 | 30% | 0.85 | |
IV- Special sense symptoms | Hearing problems Days | 7.5 | 5 | 11.9 | 119 | 129 | 13% | 0.94 |
Visual disturbances Days | 7.3 | 4 | 9.9 | 59 | 145 | 15% | 0.40 | |
Dry eyes Days | 7.9 | 5 | 11 | 63 | 185 | 19% | 0.88 | |
Loss of smell Days | 15.9 | 10 | 19.5 | 149 | 604 | 62% | 0.63 | |
Loss of taste Days | 13.9 | 9 | 16.6 | 119 | 555 | 57% | 0.60 | |
V- Respiratory system symptoms | Cough Days | 11 | 7 | 12.8 | 120 | 457 | 47% | 0.09 |
Breathlessness and chest tightness Days | 9 | 6 | 10.7 | 119 | 388 | 40% | 0.45 | |
VI- Gastrointestinal symptoms | Lack of appetite Days | 9.4 | 7 | 8 | 59 | 455 | 46% | 0.003* |
Nausea Days | 6.9 | 5 | 7 | 59 | 313 | 32% | 0.002* | |
Diarrhea Days | 6.4 | 4 | 8.8 | 119 | 402 | 41% | 0.42 | |
Abdominal pain Days | 6 | 4 | 6.6 | 44 | 253 | 26% | 0.02* |
*p<0.05 considered statistically significant. P values were calculated by ANOVA and LSD tests using SPSS software.
The mean (±SD) age of the subjects was 37.69 (±10.767) years.